A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases

Dirk Rades, Juergen Dunst, Steven E. Schild

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Purpose: To create a scoring system to estimate survival of patients who received whole-brain radiotherapy (WBRT) for brain metastases. Material and Methods: Based on a multivariate analysis of 1,085 retrospectively analyzed patients, a scoring system was developed. This score was based on the four significant prognostic factors found in the multivariate analysis including: age, performance status, extracranial metastases at the time of WBRT, and interval between tumor diagnosis and WBRT. The score for each prognostic factor was determined by dividing the 6-month survival rate (in %) by 10. The total score represented the sum of the partial scores for each prognostic factor. Total scores ranged from 9 to 18 points, and patients were divided into four groups. For each group, survival was compared for short-course (5 × 4 Gy) versus longer-course WBRT (10 × 3 Gy/20 × 2 Gy). Results: Actuarial 6-month survival rates were 6% for patients with scores of 9-10 points, 15% for those with scores of 11-13 points, 43% for those with scores of 14-16 points, and 76% for those with scores of 17-18 points (p < 0.001). Longer-course WBRT was not associated with better survival than short-course WBRT in any of the four groups. Conclusion: Patients with brain metastases receiving WBRT can be grouped with this score to estimate survival. Short-course and longer-course WBRT resulted in similar survival in all groups studied. However, in the more favorable patients with scores of 17-18, longer-course WBRT with lower doses per fraction should be considered, as these schedules have been associated with less neurocognitive toxicity.

Original languageEnglish (US)
Pages (from-to)251-255
Number of pages5
JournalStrahlentherapie und Onkologie
Volume184
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Radiotherapy
Neoplasm Metastasis
Survival
Brain
Multivariate Analysis
Survival Rate
Appointments and Schedules

Keywords

  • Brain metastases
  • Score
  • Survival
  • Whole-brain radiotherapy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cancer Research
  • Radiological and Ultrasound Technology

Cite this

A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. / Rades, Dirk; Dunst, Juergen; Schild, Steven E.

In: Strahlentherapie und Onkologie, Vol. 184, No. 5, 05.2008, p. 251-255.

Research output: Contribution to journalArticle

@article{f66dec39cc58470eac39ddeece0fb64c,
title = "A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases",
abstract = "Purpose: To create a scoring system to estimate survival of patients who received whole-brain radiotherapy (WBRT) for brain metastases. Material and Methods: Based on a multivariate analysis of 1,085 retrospectively analyzed patients, a scoring system was developed. This score was based on the four significant prognostic factors found in the multivariate analysis including: age, performance status, extracranial metastases at the time of WBRT, and interval between tumor diagnosis and WBRT. The score for each prognostic factor was determined by dividing the 6-month survival rate (in {\%}) by 10. The total score represented the sum of the partial scores for each prognostic factor. Total scores ranged from 9 to 18 points, and patients were divided into four groups. For each group, survival was compared for short-course (5 × 4 Gy) versus longer-course WBRT (10 × 3 Gy/20 × 2 Gy). Results: Actuarial 6-month survival rates were 6{\%} for patients with scores of 9-10 points, 15{\%} for those with scores of 11-13 points, 43{\%} for those with scores of 14-16 points, and 76{\%} for those with scores of 17-18 points (p < 0.001). Longer-course WBRT was not associated with better survival than short-course WBRT in any of the four groups. Conclusion: Patients with brain metastases receiving WBRT can be grouped with this score to estimate survival. Short-course and longer-course WBRT resulted in similar survival in all groups studied. However, in the more favorable patients with scores of 17-18, longer-course WBRT with lower doses per fraction should be considered, as these schedules have been associated with less neurocognitive toxicity.",
keywords = "Brain metastases, Score, Survival, Whole-brain radiotherapy",
author = "Dirk Rades and Juergen Dunst and Schild, {Steven E.}",
year = "2008",
month = "5",
doi = "10.1007/s00066-008-1831-5",
language = "English (US)",
volume = "184",
pages = "251--255",
journal = "Strahlentherapie und Onkologie : Organ der Deutschen R{\"o}ntgengesellschaft ... [et al]",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "5",

}

TY - JOUR

T1 - A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases

AU - Rades, Dirk

AU - Dunst, Juergen

AU - Schild, Steven E.

PY - 2008/5

Y1 - 2008/5

N2 - Purpose: To create a scoring system to estimate survival of patients who received whole-brain radiotherapy (WBRT) for brain metastases. Material and Methods: Based on a multivariate analysis of 1,085 retrospectively analyzed patients, a scoring system was developed. This score was based on the four significant prognostic factors found in the multivariate analysis including: age, performance status, extracranial metastases at the time of WBRT, and interval between tumor diagnosis and WBRT. The score for each prognostic factor was determined by dividing the 6-month survival rate (in %) by 10. The total score represented the sum of the partial scores for each prognostic factor. Total scores ranged from 9 to 18 points, and patients were divided into four groups. For each group, survival was compared for short-course (5 × 4 Gy) versus longer-course WBRT (10 × 3 Gy/20 × 2 Gy). Results: Actuarial 6-month survival rates were 6% for patients with scores of 9-10 points, 15% for those with scores of 11-13 points, 43% for those with scores of 14-16 points, and 76% for those with scores of 17-18 points (p < 0.001). Longer-course WBRT was not associated with better survival than short-course WBRT in any of the four groups. Conclusion: Patients with brain metastases receiving WBRT can be grouped with this score to estimate survival. Short-course and longer-course WBRT resulted in similar survival in all groups studied. However, in the more favorable patients with scores of 17-18, longer-course WBRT with lower doses per fraction should be considered, as these schedules have been associated with less neurocognitive toxicity.

AB - Purpose: To create a scoring system to estimate survival of patients who received whole-brain radiotherapy (WBRT) for brain metastases. Material and Methods: Based on a multivariate analysis of 1,085 retrospectively analyzed patients, a scoring system was developed. This score was based on the four significant prognostic factors found in the multivariate analysis including: age, performance status, extracranial metastases at the time of WBRT, and interval between tumor diagnosis and WBRT. The score for each prognostic factor was determined by dividing the 6-month survival rate (in %) by 10. The total score represented the sum of the partial scores for each prognostic factor. Total scores ranged from 9 to 18 points, and patients were divided into four groups. For each group, survival was compared for short-course (5 × 4 Gy) versus longer-course WBRT (10 × 3 Gy/20 × 2 Gy). Results: Actuarial 6-month survival rates were 6% for patients with scores of 9-10 points, 15% for those with scores of 11-13 points, 43% for those with scores of 14-16 points, and 76% for those with scores of 17-18 points (p < 0.001). Longer-course WBRT was not associated with better survival than short-course WBRT in any of the four groups. Conclusion: Patients with brain metastases receiving WBRT can be grouped with this score to estimate survival. Short-course and longer-course WBRT resulted in similar survival in all groups studied. However, in the more favorable patients with scores of 17-18, longer-course WBRT with lower doses per fraction should be considered, as these schedules have been associated with less neurocognitive toxicity.

KW - Brain metastases

KW - Score

KW - Survival

KW - Whole-brain radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=42449151738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42449151738&partnerID=8YFLogxK

U2 - 10.1007/s00066-008-1831-5

DO - 10.1007/s00066-008-1831-5

M3 - Article

VL - 184

SP - 251

EP - 255

JO - Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]

JF - Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]

SN - 0179-7158

IS - 5

ER -